As of 2026-03-18, the Relative Valuation of IDEXX Laboratories Inc (IDXX) is 496.55 USD. This relative valuation is based on P/E multiples. With the latest stock price at 586.98 USD, the upside of IDEXX Laboratories Inc based on Relative Valuation is -15.4%.
The range of the Relative Valuation is 395.05 - 594.80 USD.
| Range | Selected | |
| Trailing P/E multiples | 30.9x - 44.7x | 37.6x |
| Forward P/E multiples | 26.6x - 39.5x | 33.2x |
| Fair Price | 395.05 - 594.80 | 496.55 |
| Upside | -32.7% - 1.3% | -15.4% |
| Date | P/E |
| 2026-03-17 | 44.11 |
| 2026-03-16 | 44.07 |
| 2026-03-13 | 43.12 |
| 2026-03-12 | 42.93 |
| 2026-03-11 | 45.13 |
| 2026-03-10 | 45.00 |
| 2026-03-09 | 45.88 |
| 2026-03-06 | 45.72 |
| 2026-03-05 | 46.51 |
| 2026-03-04 | 48.75 |
| 2026-03-03 | 47.76 |
| 2026-03-02 | 47.85 |
| 2026-02-27 | 49.35 |
| 2026-02-26 | 49.65 |
| 2026-02-25 | 49.40 |
| 2026-02-24 | 48.79 |
| 2026-02-23 | 46.83 |
| 2026-02-20 | 47.77 |
| 2026-02-19 | 47.40 |
| 2026-02-18 | 47.71 |
| 2026-02-17 | 47.06 |
| 2026-02-13 | 47.30 |
| 2026-02-12 | 46.38 |
| 2026-02-11 | 48.75 |
| 2026-02-10 | 48.59 |
| 2026-02-09 | 48.08 |
| 2026-02-06 | 48.44 |
| 2026-02-05 | 48.37 |
| 2026-02-04 | 48.32 |
| 2026-02-03 | 47.54 |
| 2026-02-02 | 48.07 |
| 2026-01-30 | 50.39 |
| 2026-01-29 | 50.86 |
| 2026-01-28 | 51.68 |
| 2026-01-27 | 52.21 |
| 2026-01-26 | 52.44 |
| 2026-01-23 | 52.14 |
| 2026-01-22 | 51.93 |
| 2026-01-21 | 52.34 |
| 2026-01-20 | 51.56 |
| 2026-01-16 | 53.76 |
| 2026-01-15 | 53.52 |
| 2026-01-14 | 53.39 |
| 2026-01-13 | 53.66 |
| 2026-01-12 | 54.47 |
| 2026-01-09 | 53.61 |
| 2026-01-08 | 53.54 |
| 2026-01-07 | 53.70 |
| 2026-01-06 | 53.12 |
| 2026-01-05 | 51.27 |